(2) 2011 National Academy of Sciences. Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education and Research, 2010 Decision Resources, and Harstall, C. How prevalent is chronic pain? Pain Clinical Updates X, 1–4 (2003).
(3) IMS, NSP, NPA and Defined Health 2010 Estimates.
(4) Melnikova, I, Pain Market, Nature Reviews Drug Discovery, Volume 9, 589-90 ( August 2010).
(5) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee, " Risk Evaluation and Mitigation Strategies (REMS) for Extended-Release and Long-Acting Opioid Analgesics", July 23-4, 2010.(6) Morbidity and Mortality Weekly Report (MMWR) , Emergency Department Visits Involving Nonmedical Use of Selected Prescription Drugs --- United States, 2004—2008, 59(23);705-709 ( June 2010). SOURCE Nektar Therapeutics